Address
Other Office
4633 World Parkway Circle
St Louis, MO 63134
United States
Website
Recent investment activity
KANDO id: 36343
Corporate information
Founders
Official name
Triathlon Medical Ventures Limited Liability Company
Registration country
Overview
Triathlon Medical Ventures is a Midwest-based venture capital firm that invests exclusively in the life sciences. We provide equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs.
We are geographically focused on early stage opportunities in the Midwest and later stage companies nationwide. We are headquartered in Cincinnati with a partner also in Indianapolis. The partners are industry veterans with extensive experience as both operational managers and venture capitalists.
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Triathlon Medical Ventures LP | Venture | 2004 | USD | 105,000,000 |
| Triathlon Medical Ventures II | Venture |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 28| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Cardio Polymers Inc | Biopharmaceutical company focused on non-destructive treatments for cardiac conduction abnormalities. | N/A | |||
|
|
Celleration Inc | Medical device company focused on developing and commercializing therapeutic ultrasound products | Series D | |||
|
|
CoLucid Pharmaceuticals | Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. | N/A | |||
|
|
CoLucid Pharmaceuticals | Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. | Series B | |||
|
|
CoLucid Pharmaceuticals | Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. | Series A | |||
|
|
CS-Keys Inc | Biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. | Series A | |||
|
|
Endocyte Inc | Folate-based cancer and autoimmune disease therapies | Series C | |||
|
|
Expanding Orthopedics Inc | A medical device company developing orthopedic implants that use expandable metal and polymer components. | N/A | |||
|
|
HydroCision Inc | HydroCision is the leading developer, manufacturer, and marketer of fluidjet based surgical tools for the spine market. | Series G | |||
|
|
Juventas Therapeutics Inc | N/A | ||||
|
|
Kereos Inc | Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. | N/A | |||
|
|
Mitralign Inc | Percutaneous mitral valve repair system. | Series D | |||
|
|
Mitralign Inc | Percutaneous mitral valve repair system. | Series C | |||
|
|
Pradama Inc | A specialty pharmaceutical company focused on the development and commercialization of products to treat bone diseases. | N/A | |||
|
|
Remon Medical Technologies Inc | Medical device company providing smart, miniature implants. | N/A | |||
|
|
Renal Solutions Inc | Series B | ||||
|
|
SironRx Therapeutics Inc | Developer of regenerative therapies for the treatment of dermal wound repair | N/A | |||
|
|
SuturTek Inc | N/A | ||||
|
|
Symphony Medical Inc | Series B | ||||
|
|
Tolera Therapeutics Inc | Series B | ||||
|
|
Tolera Therapeutics Inc | Series A | ||||
|
|
Aerpio Therapeutics Inc | Series A | ||||
|
|
Akebia Therapeutics Inc | Series B | ||||
|
|
Akebia Therapeutics Inc | Series A | ||||
|
|
Biovex Inc (Biovex Group Inc) | Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. | Series F |
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| John Rice (founder) | CincyTech USA | Managing Director
Life Sciences |